SEC Says Biotech Co. Duped Investors Over COVID-19 Tests
Decision Diagnostics Corp.'s chief executive went on a publicity spree boasting that the biotechnology company could accurately test for COVID-19 with a finger-prick of blood and provide near-instant results, but it...To view the full article, register now.
Already a subscriber? Click here to view full article